3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
12
Burkitt Lymphoma
8
Lymphoma, Follicular
7
Sarcoma
5
Lymphoma, Non-Hodgkin
5
Hodgkin Disease
5
Neoplasms
4
Lymphoma
4
Wilms Tumor
3
Sarcoma, Ewing
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Lymphoma, B-Cell
3
Liposarcoma
3
Endometrial Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Ganglioneuroblastoma
2
Fallopian Tube Neoplasms
2
Down Syndrome
2
Dermatofibrosarcoma
2
Interventions
fludarabine phosphate
2
fludarabine
2
blinatumomab
2
Cyclophosphamide
2
tislelizumab
1
tisagenlecleucel
1
obinutuzumab
1
Radiotherapy
1
Monatide (IMS 3015)
1
HMPL-013
1
Cetuximab
1
Blood Specimen Collection
1
Biological Assay
1
AP 1903 reagent
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Doxorubicin
×
30 days
×
Clear all
No trials found.